Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUANC.L Regulatory News (UANC)

  • There is currently no data for UANC

Recommended Cash Acquisition

19 Jan 2021 11:46

RNS Number : 1922M
Urban&Civic plc
19 January 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

19 January 2021 

Recommended Cash Acquisition

of

URBAN&CIVIC plc

by

THE WELLCOME TRUST LIMITED, AS TRUSTEE OF THE WELLCOME TRUST 

Court sanction of Scheme and suspension of trading of Urban&Civic Shares

Urban&Civic plc ("Urban&Civic") announces that the Court of Session in Scotland has today sanctioned the scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme") by which the recommended all cash offer for the entire issued and to be issued share capital of Urban&Civic (the "Acquisition") by The Wellcome Trust Limited, as trustee of the Wellcome Trust ("Wellcome"), is being implemented. Full details of the Acquisition and the Offer are set out in the scheme document published by Urban&Civic on 20 November 2020 (the "Scheme Document").

It is expected that the Effective Date, and therefore completion of the Acquisition, will be 21 January 2021, which is when the Court Order is intended to be delivered to the Registrar of Companies. There has been no change to the expected timetable for the remaining steps to complete the Acquisition as set out in the announcement issued by Urban&Civic on 20 November 2020.

Additionally, Urban&Civic announces that trading in Urban&Civic Shares on the London Stock Exchange's main market for listed securities and the listing of Urban&Civic Shares on the premium segment of the Official List will each be suspended with effect from 7.30 a.m. on 21 January 2021. Applications have been made to the FCA and the London Stock Exchange in relation to the de-listing of Urban&Civic Shares from the premium segment of the Official List and the cancellation of the admission to trading of Urban&Civic Shares on the London Stock Exchange's main market for listed securities, which is expected to take place at 8.00 a.m. on 22 January 2021, subject to the Scheme becoming Effective.

Capitalised terms used but not otherwise defined in this announcement shall have the meaning given to them in the Scheme Document, a copy of which is available on the Urban&Civic website at https://www.urbanandcivic.com/investors. All references to time are to London times.

Enquiries:

 

Urban&CivicNigel Hugill

David Wood

 

 

 

+44 (0)20 7509 5555

 

J.P. Morgan Cazenove (Sole financial adviser to Urban&Civic) 

Bronson Albery

Tara Morrsion

Celia Murray

Jonty Edwards

 

+44(0)20 7742 4000 

 

FTI Consulting (Public Relations Adviser to Urban&Civic)Giles Barrie

Dido Laurimore

Email:

 

 

+44 (0)7798 926 814

+44 (0)7801 654 424

urban&civic@fticonsulting.com 

UBS (Financial Adviser to Wellcome)Ian Hart

Aadhar Patel

 

 

 

+44 (0)20 7567 8000

Brunswick (Public Relations Adviser to Wellcome)Jonathan Glass

Nina Coad

Emily Trapnell

 

 

 

+44 (0)20 7404 5959

 

CMS Cameron McKenna Nabarro Olswang LLP is retained as legal adviser to Urban&Civic. Slaughter and May is retained as legal adviser to Wellcome.

IMPORTANT NOTICES

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), and which is authorised in the United Kingdom by the PRA and regulated by the PRA and the FCA, is acting as financial adviser exclusively for Urban&Civic and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Urban&Civic for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS is acting as financial adviser to Wellcome and no one else in connection with the Offer. In connection with such matters, UBS, its affiliates and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to any other person for providing the protections afforded to their clients or for providing advice in relation to the Acquisition, the contents of this announcement or any other matter referred to herein.

This announcement and the documents required to be published pursuant to Rule 26.1 of the City Code will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Wellcome's website at https://wellcome.org/about-us/investments and Urban&Civic's website at https://www.urbanandcivic.com/investors promptly and in any event by no later than 12 noon (London time) on the Business Day following the date of this announcement. The content of the websites referred to in this announcement are not incorporated into and do not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPSFLFFUEFSELF
Date   Source Headline
6th Dec 20191:11 pmRNSDirector/PDMR Shareholding
28th Nov 20197:00 amRNSRESULTS FOR THE YEAR TO 30 SEPTEMBER 2019
25th Nov 20194:38 pmRNSDirectorate Change
18th Nov 20192:46 pmRNSBoard Changes
7th Oct 20197:00 amRNSNotice of Results
26th Sep 20193:31 pmRNSDirector Declaration
5th Sep 20193:16 pmRNSHolding(s) in Company
16th Jul 20191:27 pmRNSDirector/PDMR Shareholding
28th Jun 201911:10 amRNSDirector/PDMR Shareholding
27th Jun 20191:11 pmRNSAdditional Listing
14th Jun 20199:30 amRNSScrip Dividend Reference Price
30th May 20197:00 amRNSRESULTS FOR THE SIX MONTHS TO 31 MARCH 2019
23rd May 20193:46 pmRNSBoard Committee Change
14th May 20197:00 amRNSRESOLUTION TO GRANT CONSENT AT WATERBEACH
10th May 20199:00 amRNSAppointment of Non-Executive Directors
30th Apr 20197:00 amRNSTransfer to the Premium Listing Segment
28th Mar 20196:16 pmRNSNotification of Transfer to Premium Listing
21st Mar 20192:59 pmRNSNotice of Results
1st Mar 20193:22 pmRNSDirector/PDMR Shareholding
13th Feb 20192:38 pmRNSResult of AGM
13th Feb 201910:00 amRNSAGM Statement
1st Feb 201911:04 amRNSAdditional Listing
23rd Jan 20194:58 pmRNSDirectorate Change
17th Jan 201911:19 amRNSScrip Dividend Reference Price
7th Jan 20193:25 pmRNSAnnual Report & Accounts and Notice of 2019 AGM
18th Dec 20183:25 pmRNSDirector/PDMR Shareholding
7th Dec 20182:50 pmRNSDirector/PDMR Shareholding
6th Dec 20183:28 pmRNSHolding(s) in Company
6th Dec 20181:54 pmRNSDirector/PDMR Shareholding
29th Nov 20187:00 amRNSFinal Results
1st Oct 20187:00 amRNSNOTICE OF FULL YEAR RESULTS
27th Sep 20187:00 amRNSTrading Update
17th Sep 20183:11 pmRNSHolding(s) in Company
18th Jul 20182:53 pmRNSHolding(s) in Company
17th Jul 201811:28 amRNSDirector/PDMR Shareholding
13th Jul 201811:32 amRNSDirector/PDMR Shareholding
12th Jul 201811:30 amRNSDirector/PDMR Shareholding
12th Jul 201811:28 amRNSHolding(s) in Company
11th Jul 20184:44 pmRNSDirectorate Change
11th Jul 20182:30 pmRNSDirector/PDMR Shareholding
11th Jul 20182:28 pmRNSHolding(s) in Company
10th Jul 20184:33 pmRNSResult of sale of GI Partners stake in U&C
9th Jul 20185:03 pmRNSProposed sale of GI Partners stake in U&C plc
4th Jul 20183:21 pmRNSAdditional Listing
14th Jun 20189:00 amRNSScrip Dividend Reference Price
31st May 20187:05 amRNSRESULTS FOR THE SIX MONTHS TO 31 MARCH 2018
5th Apr 20182:30 pmRNSNOTICE OF HALF YEAR RESULTS
20th Mar 20187:00 amRNSUpdate re New Urban Extension at St Neots
8th Mar 20187:00 amRNSContracts exchanged on 785 acre strategic site
28th Feb 20181:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.